Duncan leads GSK’s Developing Countries and Market Access operating unit. The group was formed in August 2010 and integrates GSK's pharmaceutical and vaccines business in Least Developed Countries (LDCs) into one unit. The group has a dedicated focus on delivering the strategic approaches needed to expand access to medicines for patients in LDCs. The new group also includes GSK’s Market Access function which supports pricing strategy and policy for the wider Emerging Markets region within the Company. Duncan is also a Board member of ViiV Healthcare, a global specialist HIV company established by GSK and Pfizer to deliver advances in treatment and care for people living with HIV. Duncan was previously Senior Vice President, Global Communications. During his time in this role Duncan was the sponsor of GSK's strategic priority on corporate responsibility and was active in supporting the increase in GSK’s ambition and creativity around improving access to medicines for the world’s poorest patients. Duncan joined GSK in 1991. Prior to his Communications role he was Vice President, Global Investor Relations and Competitive Excellence. Duncan has a degree in Chemistry and is also a Chartered Accountant.